Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory Affairs Professionals Society Meeting In Brief

This article was originally published in The Gray Sheet

Executive Summary

PMA supplement guidance, finally?: "I'm going to go out on a limb and say it will be out by the end of the calendar year," Office of Device Evaluation Director Donna-Bea Tillman said Oct. 16 at the Regulatory Affairs Professionals Society (RAPS) annual meeting in Baltimore in reference to a highly-anticipated PMA product modification guidance. The guidance, which is expected to define specific PMA supplement types and lay out criteria for when to proceed with each, will replace a 1998 guidance on the topic that FDA removed from its website in 2005 (1"The Gray Sheet" May 30, 2005, p. 3). CDRH PMA Section Director Thinh Nguyen had told an audience at the 2005 RAPS meeting to expect the guidance in early 2006. "It's been a very difficult guidance. A lot of different people have had to see it and weigh in on it," Tillman said. "We know that the industry wants that guidance"...
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT024119

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel